[Epileptic crisis after antimalaria chemoprophylaxis with chloroquine].
Guilloton
L
L
Burckard
E
E
Fresse
S
S
Drouet
A
A
Felten
D
D
D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D002738:Chloroquine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000078306:Clobazam; D004828:Epilepsies, Partial / Q000150:complications / Q000188:drug therapy; D004827:Epilepsy / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D008875:Middle Aged; D002727:Proguanil / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000962:Antimalarials; D001569:Benzodiazepines; D000078306:Clobazam; D002738:Chloroquine; D002727:Proguanil
Crise épileptique après chimioprophylaxie antipalustre par chloroquine.